CML is a clonal myeloproliferative disorder, that is characterized by the presence of the Philadelphia chromosome t(9;22) leading to the expression of BCR-ABL, an oncogenic fusion protein with constitutive tyrosine kinase activity [9]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.